# Jörg Mahlich

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jorg-mahlich/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,837 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 26 |
| i10-index | 59 |
| Last Known Institution | Miltenyi Biotec (Germany) |
| OpenAlex ID | https://openalex.org/A5088342461 |
| ORCID iD | 0000-0003-1110-2793 |
| Works | 163 |

## Researcher papers

- [Understanding the global measurement of willingness to pay in health](https://scholariq.org/papers/understanding-the-global-measurement-of-willingness-to-pay-in-health/)
- [Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan](https://scholariq.org/papers/persistence-with-biologic-agents-for-the-treatment-of-rheumatoid-arthritis-in/)
- [Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database](https://scholariq.org/papers/persistence-rates-and-medical-costs-of-biological-therapies-for-psoriasis/)
- [Estimating Prevalence and Healthcare Utilization for Treatment-Resistant Depression in Japan: A Retrospective Claims Database Study](https://scholariq.org/papers/estimating-prevalence-and-healthcare-utilization-for-treatment-resistant/)
- [Cultural beliefs, utility values, and health technology assessment](https://scholariq.org/papers/cultural-beliefs-utility-values-and-health-technology-assessment/)
- [Economic burden of osteoporotic fractures in Austria](https://scholariq.org/papers/economic-burden-of-osteoporotic-fractures-in-austria/)
- [Patient preferences for HIV/AIDS therapy - a discrete choice experiment](https://scholariq.org/papers/patient-preferences-for-hiv-aids-therapy-a-discrete-choice-experiment/)
- [The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan](https://scholariq.org/papers/the-determinants-of-pharmaceutical-r-and-amp-d-expenditures-evidence-from-japan/)
- [Pharmaceutical regulation in Europe and its impact on corporate R&D](https://scholariq.org/papers/pharmaceutical-regulation-in-europe-and-its-impact-on-corporate-r-and-amp-d/)
- [Shared Decision-Making in Patients With Prostate Cancer in Japan: Patient Preferences Versus Physician Perceptions](https://scholariq.org/papers/shared-decision-making-in-patients-with-prostate-cancer-in-japan-patient/)
- [Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study](https://scholariq.org/papers/treatment-patterns-and-medical-cost-of-systemic-lupus-erythematosus-patients-in/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Innovation Policy and R&D](https://scholariq.org/topics/innovation-policy-and-r-and-d/)

## Researcher university

- [Miltenyi Biotec (Germany)](https://scholariq.org/institutions/miltenyi-biotec-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.